TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group
(2014) In BMC Cancer 14.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/285b058b-7e9c-478b-baf7-0d8bce975efc
- author
- Jørgensen, Charlotte Levin Tykjær LU ; Bjerre, Christina ; Ejlertsen, Bent ; Bjerre, Karsten D. ; Balslev, Eva ; Bartels, Annette ; Brünner, Nils and Nielsen, Dorte Lisbet
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- in
- BMC Cancer
- volume
- 14
- article number
- 360
- publisher
- BioMed Central (BMC)
- external identifiers
-
- scopus:84904053589
- ISSN
- 1471-2407
- DOI
- 10.1186/1471-2407-14-360
- language
- English
- LU publication?
- no
- id
- 285b058b-7e9c-478b-baf7-0d8bce975efc
- date added to LUP
- 2017-04-18 14:33:45
- date last changed
- 2022-03-09 02:21:22
@article{285b058b-7e9c-478b-baf7-0d8bce975efc,
author = {{Jørgensen, Charlotte Levin Tykjær and Bjerre, Christina and Ejlertsen, Bent and Bjerre, Karsten D. and Balslev, Eva and Bartels, Annette and Brünner, Nils and Nielsen, Dorte Lisbet}},
issn = {{1471-2407}},
language = {{eng}},
publisher = {{BioMed Central (BMC)}},
series = {{BMC Cancer}},
title = {{TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group}},
url = {{http://dx.doi.org/10.1186/1471-2407-14-360}},
doi = {{10.1186/1471-2407-14-360}},
volume = {{14}},
year = {{2014}},
}